KR100887377B1 - Nutraceutical for children and teenagers - Google Patents
Nutraceutical for children and teenagers Download PDFInfo
- Publication number
- KR100887377B1 KR100887377B1 KR1020070023314A KR20070023314A KR100887377B1 KR 100887377 B1 KR100887377 B1 KR 100887377B1 KR 1020070023314 A KR1020070023314 A KR 1020070023314A KR 20070023314 A KR20070023314 A KR 20070023314A KR 100887377 B1 KR100887377 B1 KR 100887377B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- parts
- dha
- dietary supplement
- amylase
- Prior art date
Links
- 239000002417 nutraceutical Substances 0.000 title 1
- 235000021436 nutraceutical agent Nutrition 0.000 title 1
- 235000015872 dietary supplement Nutrition 0.000 claims abstract description 22
- 239000000843 powder Substances 0.000 claims abstract description 13
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 11
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims abstract description 10
- 102000004139 alpha-Amylases Human genes 0.000 claims abstract description 9
- 108090000637 alpha-Amylases Proteins 0.000 claims abstract description 9
- 229940024171 alpha-amylase Drugs 0.000 claims abstract description 9
- 229960002079 calcium pantothenate Drugs 0.000 claims abstract description 9
- 239000002775 capsule Substances 0.000 claims abstract description 3
- 239000008187 granular material Substances 0.000 claims abstract description 3
- 239000003826 tablet Substances 0.000 claims abstract description 3
- 239000000203 mixture Substances 0.000 claims description 6
- 238000009472 formulation Methods 0.000 claims 1
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 abstract description 8
- 239000011575 calcium Substances 0.000 abstract description 7
- 230000012010 growth Effects 0.000 abstract description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 6
- 238000010521 absorption reaction Methods 0.000 abstract description 6
- 210000004958 brain cell Anatomy 0.000 abstract description 6
- 229910052791 calcium Inorganic materials 0.000 abstract description 6
- 235000016709 nutrition Nutrition 0.000 abstract description 6
- 230000007423 decrease Effects 0.000 abstract description 5
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 abstract description 4
- 230000036039 immunity Effects 0.000 abstract description 4
- 238000002156 mixing Methods 0.000 abstract description 4
- 230000035764 nutrition Effects 0.000 abstract description 4
- 235000019161 pantothenic acid Nutrition 0.000 abstract description 4
- 239000011713 pantothenic acid Substances 0.000 abstract description 4
- 229940055726 pantothenic acid Drugs 0.000 abstract description 4
- 239000007788 liquid Substances 0.000 abstract description 3
- 239000000654 additive Substances 0.000 abstract description 2
- 230000000996 additive effect Effects 0.000 abstract description 2
- 238000003860 storage Methods 0.000 abstract description 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 239000013589 supplement Substances 0.000 abstract 1
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 22
- 229940090949 docosahexaenoic acid Drugs 0.000 description 11
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 11
- 230000018109 developmental process Effects 0.000 description 5
- 210000004556 brain Anatomy 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical group CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- 241000222518 Agaricus Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000219357 Cactaceae Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 241000371652 Curvularia clavata Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 108010001441 Phosphopeptides Proteins 0.000 description 1
- 240000001890 Ribes hudsonianum Species 0.000 description 1
- 235000016954 Ribes hudsonianum Nutrition 0.000 description 1
- 235000001466 Ribes nigrum Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 235000007215 black sesame Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 235000021329 brown rice Nutrition 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 229940057059 monascus purpureus Drugs 0.000 description 1
- 230000021332 multicellular organism growth Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 229940012843 omega-3 fatty acid Drugs 0.000 description 1
- 230000004203 pancreatic function Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/06—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
Abstract
본 발명은 건강보조식품에 관한 것으로, α-아밀라아제 100중량부에 대하여, 실크펩타이드 10~20중량부, DHA 0.5~2중량부, 판토텐산칼슘 0.1~0.5중량부를 포함하고 있으며, 액상인 DHA를 제외한 각각의 성분을 건조분말상태로 혼합하여 용이하게 제조할 수 있으며, 보관, 섭취의 편의성을 위하여 부가물을 첨가하여 캡슐, 정제, 과립 등의 형태로 제조할 수도 있다.The present invention relates to a dietary supplement, which contains 10-20 parts by weight of silk peptide, 0.5-2 parts by weight of DHA, and 0.1-0.5 parts by weight of calcium pantothenate, based on 100 parts by weight of α-amylase, except for liquid DHA. Each component may be easily prepared by mixing in a dry powder state, and may be prepared in the form of capsules, tablets, granules, etc. by adding an additive for convenience of storage and intake.
본 발명의 건강보조식품은 유아 및 청소년의 면역력 저하를 방지하고, 뇌세포를 활성화하여 기억력 및 학습능력의 저하를 방지하며, 칼슘의 흡수율을 높이고 영양을 공급하여 성장발육을 돕는 역할을 한다.The dietary supplement of the present invention prevents a decrease in immunity of infants and adolescents, activates brain cells, prevents a decrease in memory and learning ability, increases calcium absorption and provides nutrition to help growth and growth.
건강보조식품, α-아밀라아제, 실크펩타이드, DHA, 판토텐산. Supplements, α-amylase, silk peptides, DHA, pantothenic acid.
Description
건강보조식품은 각종 비타민, 미네랄 및 미량 원소, 특정한 지방산이나 아미노산 등의 섭취를 돕기 위하여, 다양한 영양 성분들 중 단일 성분, 또는 다수의 성분을 함유하도록 제조된다. 다수의 성분을 함유한 영양 보조제의 경우에는 성장기 어린이의 발육을 돕는 영양 보조제나 청소년의 두뇌 발달을 돕는 영양 보조제, 임산부의 빈혈을 방지하는 영양 보조제, 갱년기 여성의 골다공증을 방지하는 영양 보조제 등과 같이 섭취 대상 및 섭취 목적에 적합하도록 특화된 제품도 다양하게 제공되고 있다. The dietary supplement is prepared to contain a single component or a plurality of components of various nutritional ingredients to help intake of various vitamins, minerals and trace elements, specific fatty acids or amino acids. Nutrient supplements containing a large number of ingredients, such as nutritional supplements to help develop a growing child, nutritional supplements to help adolescents' brain development, nutritional supplements to prevent anemia in pregnant women, and nutritional supplements to prevent osteoporosis in menopausal women There are also a variety of products specialized to suit the subject and intake purpose.
본 발명과 관련된 건강보조식품으로, 대한민국 공개특허 제2002-71152호 기능성 식품 조성물 및 그 제조방법에서는 검정콩, 검정옥수수, 검정쌀, 검정깨, 검정잣, 블랙커런트, 맥아를 함유하는 흑왕엑기스파우더와, 대두단백, 탈지분유, 탈지유단백, 결정포도당, 식염, 비타민C, 비타민B1, 비타민B6, 판토텐산칼슘, 스테비오사이드, 실크펩타이드, 카제인포스포펩타이드, 포도향분말, 홍국, 선인장열매, 결명자, 가시오가피엑기스파우더, 아가리쿠스버섯, 율무, 구연산, 복령, 현미배아를 혼합하여 제조한 기능성 식품을 제공하였으나, 상기 기술은 체중을 조절할 수 있는 식품의 제공이 주목적이었다.As a dietary supplement related to the present invention, in the Republic of Korea Patent Publication No. 2002-71152 functional food composition and a method for producing the same, black king extract powder containing black beans, black corn, black rice, black sesame seeds, black nuts, black currant, malt and , Soy protein, skim milk powder, skim milk protein, crystalline glucose, salt, vitamin C, vitamin B 1 , vitamin B 6 , calcium pantothenate, stevioside, silk peptide, casein phosphopeptide, grape flavor powder, red yeast, cactus fruit, However, although the functional food prepared by mixing the thorny ogapi extract powder, agaricus mushroom, yulmu, citric acid, bokyeong, brown rice embryo was provided, the technique was aimed to provide a food that can control the weight.
한편 두뇌의 발달을 돕는 건강보조식품으로, 대한민국 공개특허 제2004-0088149호 두뇌 활성 영양물질 조성물에서는 두뇌의 신경에서 핵심 신경전달체 및 호르몬을 만드는데 도움이 되는 최적의 영양소로서 포스파티딜 세린, 징코빌로바, GABA, 콜린, 판토텐산, 나이아신, 엽산, 비타민 B12, 대두레시틴, 아연, 타우린, 녹차추출물로 이루어진 조성물을 제공하였으나, 본 발명과는 구성에 차이가 있다.On the other hand, as a dietary supplement to help the development of the brain, Korean Patent Publication No. 2004-0088149, the brain active nutritional composition of phosphatidyl serine, ginkgo biloba, as an optimal nutrient to help to make the core neurotransmitters and hormones in the nerves of the brain GABA, choline, pantothenic acid, niacin, folic acid, vitamin B 12 , soybean lecithin, zinc, taurine, green tea extract composition was provided, but the composition is different from the present invention.
본 발명에서는 α-아밀라아제, 실크펩타이드, DHA, 판토텐산칼슘을 포함하는 유아 및 청소년을 위한 건강보조식품을 제공한다.The present invention provides a dietary supplement for infants and adolescents, including α-amylase, silk peptide, DHA, calcium pantothenate.
본 발명에서는 유아 및 청소년의 면역력 저하를 방지하고, 뇌세포를 활성화하여 기억력 및 학습능력의 저하를 방지하며, 칼슘의 흡수율을 높이고 영양을 공급하여 성장발육을 도울 수 있는 건강보조식품을 제공하고자 한다.In the present invention, it is intended to provide a health supplement that can prevent the lowering of immunity of infants and adolescents, activate brain cells to prevent memory and learning, and increase calcium absorption and supply nutrition to help growth and development. .
본 발명은 건강보조식품은 α-아밀라아제, 실크펩타이드, DHA, 판토텐산칼슘을 포함하는 것을 특징으로 한다.The health supplement is characterized in that it comprises α-amylase, silk peptide, DHA, calcium pantothenate.
α-아밀라아제는 글루코오스의 α-l, 4-결합에 작용하는 효소로 녹말이나 글리코겐 등을 절단하는 역할을 한다. α-아밀라아제는 침이나 이자액에 포함되어 있으며, 맥아, 곰팡이, 세균 등에도 함유되어 있다.α-amylase is an enzyme that acts on α-l and 4-bonds of glucose and cleaves starch or glycogen. α-amylase is contained in saliva and interest solution, and it is also contained in malt, fungus, bacteria and the like.
실크펩타이드는 고분자 상태의 명주실을 아미노산 1개 내지 수개의 저분자 상태로 분해시킨 것을 말한다. 단백질은 인체의 주요 구성성분으로 각종 호르몬, 피부, 손톱, 머리카락 등을 이루고 있으며, 명주실은 단백질로 이루어져 있으므로 훌륭한 단백질의 공급원이 될 수 있으나, 고분자 상태로는 섭취하여도 소화흡수가 되지 않는 문제가 있으므로 잘게 분해하여 섭취하는 것이 바람직하다.Silk peptide refers to the decomposition of the silk thread of the polymer state into 1 to several low molecular states. Protein is the main constituent of the human body, which consists of various hormones, skin, nails, hair, etc., and silk thread is composed of protein, so it can be a good source of protein. Therefore, it is desirable to break down and eat finely.
실크펩타이드는 명주실을 가수분해하여 흡수율이 매우 높은 특징이 있으며, 필수아미노산 8종을 포함하여 18종의 다양한 천연아미노산을 함유하고 있다. 그 중에서도 시스틴과 세린은 췌장의 기능을 정상화하여 인슐린 분비를 도움으로써 당뇨병을 개선하는 역할을 하고, 알라닌과 아스파라긴은 간의 기능을 강화시켜 해독작용을 돕는 역할을 하며, 발린은 유아 및 청소년의 성장발육과 두뇌개발을 돕고, 티로신은 기억력 증대 및 치매 예방의 역할을 하고, 메티오닌은 지방간을 예방 및 탈모 방지의 역할을 하며, 아르기닌은 노폐물 제거 및 만성피로 개선의 역할을 하는 것으로 알려져 있다. 특히, 세린은 칼슘을 가용화 상태로 유지하는 역할을 하므로, 칼슘의 흡수율을 높이는 특징이 있다.Silk peptide is characterized by very high absorption rate by hydrolyzing silk yarn, and contains 18 kinds of various natural amino acids including 8 essential amino acids. Among them, cystine and serine help to improve diabetes by normalizing pancreatic function and help insulin secretion, and alanine and asparagine help detoxification by strengthening liver function, and valine is the growth and development of infants and adolescents. It is known that tyrosine plays a role in memory and dementia prevention, methionine plays a role in preventing fatty liver and hair loss, and arginine plays a role in eliminating waste and improving chronic fatigue. In particular, since serine plays a role of maintaining calcium in a solubilized state, it is characterized by increasing the absorption rate of calcium.
DHA(Docosahexaenoic Acid)는 고도의 불포화지방산(Polyunsaturated Fatty Acid)으로, 인간을 포함한 고등동물의 체내에서는 합성되지 않으므로 DHA 생합성 능력이 있는 식물성 플랑크톤 및 해조류로부터 섭취해야 한다. DHA는 오메가 3 지 방산의 일종으로, 혈중 콜레스테롤을 낮추어 동맥경화증 등의 심혈관계 질환을 예방하고, 뇌세포를 활성화하여 기억력 및 학습능력의 저하를 방지하는 역할을 하며, 항암효과도 있는 것으로 알려져 있다. 또한, DHA는 뇌세포의 구성성분이므로 태아 및 영, 유아의 뇌신경계 발달에 중대한 영향을 미칠 수 있으므로 성장기 어린이나 산모의 경우 결핍되지 않도록 각별한 주의가 필요하다.DHA (Docosahexaenoic Acid) is a highly unsaturated fatty acid (Polyunsaturated Fatty Acid). Since it is not synthesized in the body of higher animals including humans, it should be taken from phytoplankton and algae with DHA biosynthesis ability. DHA is a type of omega-3 fatty acid. It lowers blood cholesterol, prevents cardiovascular diseases such as atherosclerosis, activates brain cells, prevents memory and learning loss, and has anti-cancer effects. . In addition, DHA is a component of brain cells, so it can have a significant impact on the development of the brain nervous system of the fetus, young, infants, so special care should be taken to avoid deficiency in the growing children or mothers.
판토텐산(Pantothenic Acid)은 비타민 B 복합체에 속하는 수용성 비타민의 일종으로, 생체 내에서는 아세틸 CoA의 성분으로 함유되어 보조효소로 각종 대사에 관여하므로 조직기능의 정상화, 신체성장 및 건강유지에 필수적인 성분이며, 피로를 방지하고 항생물질로 인한 부작용을 줄이며 상처의 치유를 촉진하고 피부와 모발을 보호하는 역할을 한다. 동식물계에 미량이지만 광범위하게 분포하며 특히 효모, 간장, 계란에 많이 함유되어 있다. 판토텐산칼슘(화학식:C18H32O10N2Ca)은 무취의 백색분말로 쓴 맛을 지니고 있으며, 건조상태에서는 공기, 열, 일광에 안정한 특징이 있다.Pantothenic Acid (Pantothenic Acid) is a water-soluble vitamin belonging to the vitamin B complex, and is contained in the body as an ingredient of acetyl CoA and is involved in various metabolisms as coenzymes, which is essential for normalizing tissue function, body growth and health maintenance. It prevents fatigue, reduces side effects from antibiotics, promotes healing of wounds, and protects skin and hair. It is a small amount in the flora and fauna, but it is widely distributed, especially in yeast, soy sauce, and eggs. Calcium Pantothenate ( C18 H 32 O 10 N 2 Ca) is a odorless white powder that has a bitter taste and is stable to air, heat, and sunlight in a dry state.
본 발명의 건강보조식품은 α-아밀라아제 100중량부에 대하여, 실크펩타이드 10~20중량부, DHA 0.5~2중량부, 판토텐산칼슘 0.1~0.5중량부를 포함하고 있으며, 액상인 DHA를 제외한 각각의 성분을 건조분말상태로 혼합하여 분말의 형태로 용이하게 제조할 수 있으며, 보관, 섭취의 편의성을 위하여 부가물을 첨가하여 캡슐, 정제, 과립 등의 형태로 제조할 수도 있다.The dietary supplement of the present invention contains 10 to 20 parts by weight of silk peptide, 0.5 to 2 parts by weight of DHA, and 0.1 to 0.5 parts by weight of calcium pantothenate, based on 100 parts by weight of α-amylase, and each component except liquid DHA. It can be easily prepared in the form of a powder by mixing in a dry powder state, and may be prepared in the form of capsules, tablets, granules, etc. by adding an additive for convenience of storage and intake.
본 발명에 따른 건강보조식품의 성분비는 상기 배합비율에 국한된 것은 아니나, 특정 성분만이 지나치게 다량 포함될 경우 전체적인 효과가 상대적으로 떨어질 수 있을 뿐 아니라, 액상인 DHA가 다량 포함되면 제제의 형태가 제한될 수 있고, 판토텐산칼슘이 다량 포함되면 쓴 맛으로 인하여 섭취에 불편함이 따르는 단점도 있으므로 상기 조성비를 벗어나지 않는 것이 바람직하다.The ingredient ratio of the dietary supplement according to the present invention is not limited to the above blending ratio, but if the amount of only a certain component is included in an excessive amount, the overall effect may not be relatively low, and if a large amount of liquid DHA is included, the form of the preparation may be limited. It can be, if the pantothenate calcium is contained in a large amount, there is also a disadvantage in that it is inconvenient to ingest due to the bitter taste, it is preferable not to deviate from the composition ratio.
[실시예]EXAMPLE
α-아밀라아제분말 100g, 실크펩타이드분말 15g, DHA 0.5g, 판토텐산칼슘분말 0.2g을 혼합하여 본 발명의 건강보조식품을 제조하였다.α-amylase powder 100g, silk peptide powder 15g, DHA 0.5g, calcium pantothenate powder 0.2g to prepare a health supplement of the present invention.
상기 실시예에 따른 건강보조식품은 분말의 형태로서 면역력 저하를 방지하고, 뇌세포를 활성화하여 기억력 및 학습능력의 저하를 방지하며, 칼슘의 흡수율을 높이고 영양을 공급하여 성장발육을 돕는 역할을 한다. 본 발명의 건강보조식품은 12개월 미만 영아의 경우 1일 2~4g, 12개월 이상의 유아, 청소년의 경우 1일 4~6g의 섭취로 원하는 효과를 얻을 수 있다.The health supplement according to the embodiment is in the form of a powder to prevent immunity deterioration, to activate the brain cells to prevent the decline of memory and learning ability, serves to help the growth and development by increasing the absorption rate of calcium and supply nutrition . The dietary supplement of the present invention can achieve the desired effect by ingestion of 2-4g per day for infants under 12 months, 4-6g per day for infants and adolescents over 12 months.
본 발명의 건강보조식품은 유아 및 청소년의 면역력 저하를 방지하고, 뇌세포를 활성화하여 기억력 및 학습능력의 저하를 방지하며, 칼슘의 흡수율을 높이고 영양을 공급하여 성장발육을 돕는 역할을 한다.The dietary supplement of the present invention prevents a decrease in immunity of infants and adolescents, activates brain cells, prevents a decrease in memory and learning ability, increases calcium absorption and provides nutrition to help growth and growth.
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020070023314A KR100887377B1 (en) | 2007-03-09 | 2007-03-09 | Nutraceutical for children and teenagers |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020070023314A KR100887377B1 (en) | 2007-03-09 | 2007-03-09 | Nutraceutical for children and teenagers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20080082708A KR20080082708A (en) | 2008-09-12 |
| KR100887377B1 true KR100887377B1 (en) | 2009-03-05 |
Family
ID=40021869
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020070023314A KR100887377B1 (en) | 2007-03-09 | 2007-03-09 | Nutraceutical for children and teenagers |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR100887377B1 (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101589467B1 (en) | 2015-05-21 | 2016-01-29 | 주식회사 쎌바이오텍 | Use of bifidobacterium bifidum cbt bf3 strain for promoting growth and nutraceutical composition for promoting growth comprising the same |
| KR101589464B1 (en) | 2015-05-21 | 2016-02-01 | 주식회사 쎌바이오텍 | New bifidobacterium strain and nutraceutical composition for improving growth comprising the same |
| KR101589465B1 (en) | 2015-05-21 | 2016-02-01 | 주식회사 쎌바이오텍 | Use of bifidobacterium breve cbt br3 strain for promoting growth and nutraceutical composition for promoting growth comprising the same |
| KR101589466B1 (en) | 2015-05-21 | 2016-02-01 | 주식회사 쎌바이오텍 | Use of bifidobacterium longum cbt bg7 strain for promoting growth and nutraceutical composition for promoting growth comprising the same |
| KR102517826B1 (en) | 2022-07-22 | 2023-04-05 | 주식회사 상상바이오 | Manufacturing method of improving composition the health and development of growing children with excellent palatability |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102610704B1 (en) * | 2023-07-17 | 2023-12-08 | 주식회사 이안스푸드글로벌 | Manufacturing method of shine muskett containing basil seeds |
| KR102594645B1 (en) * | 2023-08-01 | 2023-10-26 | 농업회사법인 청결원식품 주식회사 | Manufacturing method of black bellflower syrup |
| KR102594646B1 (en) * | 2023-08-01 | 2023-10-26 | 농업회사법인 청결원식품 주식회사 | Manufacturing method of red bellflower syrup |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20020092082A (en) * | 2001-06-02 | 2002-12-11 | 김원규 | Tonic composition |
| KR100754276B1 (en) | 2007-02-22 | 2007-09-03 | 김재현 | Nutraceutical with silk peptide and calcium |
-
2007
- 2007-03-09 KR KR1020070023314A patent/KR100887377B1/en active IP Right Grant
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20020092082A (en) * | 2001-06-02 | 2002-12-11 | 김원규 | Tonic composition |
| KR100754276B1 (en) | 2007-02-22 | 2007-09-03 | 김재현 | Nutraceutical with silk peptide and calcium |
Non-Patent Citations (1)
| Title |
|---|
| 실크 펩타이드 투여가 흰쥐의 성장 및 Stamina에 미치는 영향(한국영양학회 03 연합학술대회,조재민 등,pp.265, 2003) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101589467B1 (en) | 2015-05-21 | 2016-01-29 | 주식회사 쎌바이오텍 | Use of bifidobacterium bifidum cbt bf3 strain for promoting growth and nutraceutical composition for promoting growth comprising the same |
| KR101589464B1 (en) | 2015-05-21 | 2016-02-01 | 주식회사 쎌바이오텍 | New bifidobacterium strain and nutraceutical composition for improving growth comprising the same |
| KR101589465B1 (en) | 2015-05-21 | 2016-02-01 | 주식회사 쎌바이오텍 | Use of bifidobacterium breve cbt br3 strain for promoting growth and nutraceutical composition for promoting growth comprising the same |
| KR101589466B1 (en) | 2015-05-21 | 2016-02-01 | 주식회사 쎌바이오텍 | Use of bifidobacterium longum cbt bg7 strain for promoting growth and nutraceutical composition for promoting growth comprising the same |
| WO2016186244A1 (en) | 2015-05-21 | 2016-11-24 | 주식회사 쎌바이오텍 | Bifidobacterium breve cbt br3 strain for promoting growth and functional food composition containing same for promoting growth |
| WO2016186245A1 (en) | 2015-05-21 | 2016-11-24 | 주식회사 쎌바이오텍 | Bifidobacterium longum cbt bg7 strain and functional food composition containing same for promoting growth |
| US10597740B2 (en) | 2015-05-21 | 2020-03-24 | Cell Biotech Co., Ltd. | Bifidobacterium longum CBT BG7 strain for promotion of growth and nutraceutical composition for promotion of growth containing the same |
| US11026983B2 (en) | 2015-05-21 | 2021-06-08 | Cell Biotech Co., Ltd. | Bifidobacterium breve CBT BR3 strain for promotion of growth and nutraceutical composition for promotion of growth containing the same |
| KR102517826B1 (en) | 2022-07-22 | 2023-04-05 | 주식회사 상상바이오 | Manufacturing method of improving composition the health and development of growing children with excellent palatability |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20080082708A (en) | 2008-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100887377B1 (en) | Nutraceutical for children and teenagers | |
| CN104522832B (en) | A kind of immunologic pattern protein powder solid beverage and preparation method thereof | |
| Abbas et al. | Nutritional and therapeutic potential of sesame seeds | |
| CA2452997A1 (en) | Flax sprouts and sprouting method | |
| ES2900227T3 (en) | Iron-fortified food composition | |
| CN110074397A (en) | A kind of upgrowth and development of children tailored version clinical nutrition formula and preparation method thereof | |
| CN1135288A (en) | Biscuit good for memory | |
| Mudgil et al. | Functional Foods: Sources and Health Benefits | |
| JP2010265251A (en) | Bloodstream-promoting/improving agent | |
| CN107536021A (en) | A kind of fortification albumen composite powder and preparation method thereof | |
| JPWO2009048120A1 (en) | Astaxanthin-containing water-soluble composition | |
| CN1571637A (en) | Use of cystathionine | |
| KR20110119305A (en) | A functional beverage comprising taurine, royal jelly, red ginseng, lycii fructus, glumate and apple essence as main ingredients | |
| KR20080110129A (en) | Food composition for stimulating growth by balancing between nutritional ingredient and growth stimulating ingredient | |
| JP2017057147A (en) | Composition comprising garlic and the like, low-salinity miso, and vitamin b1 | |
| WO2008056967A1 (en) | Novel method for preparing and stabilising a nutritious amaranth product | |
| CN105494577A (en) | Nutrient easy-to-digest biscuits for preschoolers to eat | |
| CN104187669A (en) | Nutritious food having freckle-removing and beauty function and preparation method thereof | |
| CN101248871A (en) | Lowing blood sugar, blood pressure, blood fat biological food product containing jade substance component | |
| CN107136490A (en) | A kind of peptide Chinese caterpillar fungus health product | |
| ES2927738T3 (en) | Marine protein hydrolyzate with low fluoride and trimethylamine content | |
| JPH11266832A (en) | Food composition and its production | |
| CN102370131A (en) | Needle mushroom nutritious noodle and preparation method thereof | |
| CN110214939A (en) | Special medicine purposes formula nutritional powder and preparation method thereof for crowd after performing the operation | |
| WO2020234815A1 (en) | Mineral-containing nanoparticles micro-encapsulated in powder |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| E701 | Decision to grant or registration of patent right | ||
| GRNT | Written decision to grant | ||
| FPAY | Annual fee payment |
Payment date: 20121226 Year of fee payment: 5 |
|
| FPAY | Annual fee payment |
Payment date: 20140214 Year of fee payment: 6 |
|
| FPAY | Annual fee payment |
Payment date: 20150224 Year of fee payment: 7 |
|
| FPAY | Annual fee payment |
Payment date: 20160225 Year of fee payment: 8 |
|
| FPAY | Annual fee payment |
Payment date: 20180226 Year of fee payment: 10 |
|
| FPAY | Annual fee payment |
Payment date: 20190227 Year of fee payment: 11 |
|
| FPAY | Annual fee payment |
Payment date: 20200226 Year of fee payment: 12 |